Product image of Glucos Viaflo Baxter (Glucose) supplied by GNH India

Glucos Viaflo Baxter

Active Ingredient:
Glucose
Origin:
EU

Glucos Viaflo Baxter (Glucose)

Glucos Viaflo Baxter is an intravenous solution whose active ingredient is glucose. The product is supplied without a specified strength and is intended for parenteral administration. It originates from the European Union market and is classified under the broader category of glucose solutions used in clinical settings for energy provision and fluid management.

Manufacturer / TM Owner

Baxter Medical Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucos Viaflo Baxter is used in medical practice to address several clinical needs related to glucose administration and fluid balance.

  • Treatment of hypoglycemia when oral intake is not feasible.
  • Provision of caloric support in patients requiring parenteral nutrition.
  • Maintenance of blood glucose levels during surgery or intensive care.
  • Dilution and carrier for certain intravenous medications.
  • Rehydration therapy in conjunction with electrolyte replacement.

Side Effects

Glucos Viaflo Baxter may be associated with a range of side effects, which are generally categorized by frequency and severity.

Common

  • Mild hyperglycemia.
  • Local irritation at the infusion site.
  • Nausea or vomiting.
  • Headache.
  • Transient increase in serum osmolality.

Serious

  • Severe hyperglycemia leading to ketoacidosis.
  • Allergic reaction such as rash or urticaria.
  • Fluid overload causing pulmonary edema.
  • Electrolyte imbalance, particularly hyponatremia.
  • Hypotension due to rapid infusion.

Precautions & Warnings

When considering Glucos Viaflo Baxter, healthcare professionals should observe several precautionary measures to minimize risk.

  • Assess baseline blood glucose and monitor levels regularly during infusion.
  • Adjust infusion rate in patients with renal or cardiac insufficiency to avoid fluid overload.
  • Use caution in individuals with known glucose intolerance or diabetes mellitus.
  • Verify compatibility with other intravenous solutions before co-administration.
  • Ensure proper aseptic technique to prevent infection at the infusion site.
  • Review patient history for any prior allergic reactions to glucose-containing products.

Avoid Interactions

Glucos Viaflo Baxter can interact with other medications or clinical conditions, requiring careful management.

Avoid

  • Co-administration with high-dose insulin without appropriate glucose monitoring.
  • Simultaneous infusion of hypertonic saline solutions that may exacerbate hyperosmolar states.

Use with caution

  • Concurrent use of diuretics, which may affect fluid balance.
  • Administration alongside medications that influence blood glucose, such as glucocorticoids.
  • Patients receiving total parenteral nutrition, to avoid excessive caloric intake.
  • Situations involving electrolyte-altering drugs, requiring close electrolyte monitoring.

Frequently Asked Questions

The primary active ingredient in Glucos Viaflo Baxter is glucose.

Glucos Viaflo Baxter is administered intravenously, meaning it is delivered directly into a vein through an IV line.

Yes, it can be used to treat hypoglycemia when oral glucose intake is not possible or practical.

It can be incorporated into total parenteral nutrition regimens, but clinicians should monitor total caloric and glucose intake to avoid excess.

Regular monitoring of blood glucose levels, serum electrolytes, and fluid balance is recommended during infusion.

Serious side effects may include severe hyperglycemia, allergic reactions, fluid overload, and electrolyte imbalances.

Yes, patients with cardiac insufficiency should receive the solution at a controlled rate to reduce the risk of fluid overload.

Compatibility should be verified before mixing, as some drugs may be incompatible with glucose solutions.

Common mild reactions include transient hyperglycemia, local irritation at the infusion site, nausea, and headache.

The regulatory status varies by region; in many jurisdictions it is supplied under medical supervision, often requiring a prescription.

Products originating from the EU are subject to stringent manufacturing and quality control regulations that ensure consistency and safety.

The infusion should be stopped immediately, and appropriate medical treatment for the allergic reaction should be initiated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.